Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.5 GBX | +4.38% | +3.85% | +58.82% |
Feb. 14 | Futura Medical's Eroxon to soon be available on prescription | AN |
Feb. 06 | BP and Prudential help snap FTSE losing streak | AN |
Sales 2023 * | 3.1M 3.91M | Sales 2024 * | 10.08M 12.71M | Capitalization | 122M 154M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 36.9 x |
Net cash position 2023 * | 7.73M 9.74M | Net cash position 2024 * | 2.69M 3.4M | EV / Sales 2024 * | 11.8 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 12 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 67.12% |
Latest transcript on Futura Medical plc
1 day | +4.38% | ||
1 week | +3.85% | ||
1 month | -5.48% | ||
3 months | +56.98% | ||
6 months | -2.41% | ||
Current year | +58.82% |
Managers | Title | Age | Since |
---|---|---|---|
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Angela Hildreth
DFI | Director of Finance/CFO | - | 18-02-19 |
Ken James
CTO | Chief Tech/Sci/R&D Officer | - | 16-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Needham
CHM | Chairman | 68 | 21-10-07 |
Gordon Davis
BRD | Director/Board Member | 67 | Jan. 08 |
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 40.5 | +4.38% | 359,491 |
24-03-27 | 38.8 | +2.11% | 300,237 |
24-03-26 | 38 | -0.65% | 205,390 |
24-03-25 | 38.25 | +1.19% | 198,428 |
24-03-22 | 37.8 | -3.08% | 317,967 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+58.82% | 154M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |